U.K. Molecular Point of care Testing (Using NAAT) Market to 2032
Overview
The U.K. Molecular Point of care Testing (Using NAAT) Market is expected to reach a 10.19 USD Billion by 2032 and is projected to grow at a CAGR of 18.24% from 2025 to 2032.
Revenue, 2024 (USD Billion)
3.60
Forecast, 2032 (USD Billion)
10.19
CAGR, 2024 - 2032
18.24%
Report Coverage
U.K.
U.K. Molecular Point of care Testing (Using NAAT) Market 2018-2032 USD Billion
U.K. Molecular Point of care Testing (Using NAAT) Market, Key Findings (2025-2032)
Market Growth and Projections:
- Market Size (2024): 3.60 USD Billion
- Projected Market Size (2032): 10.19 USD Billion
- CAGR (2025-2032): 18.24%
Key Findings of U.K. Molecular Point of care Testing (Using NAAT) Market
- The U.K. Molecular Point of care Testing (Using NAAT) Market was valued at 3.60 USD Billion in 2024.
- The U.K. Molecular Point of care Testing (Using NAAT) Market is likely to grow at a CAGR of 18.24% during the forecast period of 2024 to 2032.
- In 2024, the Largest segment Prescription-Based Testing in Mode of Testing Segment accounted for the largest share of the market with a revenue of 3.40 USD Billion
- The fastest growing segment Direct Sales in Distribution Channel Segment grew Fastest with a CAGR of 19.95% during the forecast period from 2024 to 2032.
U.K. Molecular Point of care Testing (Using NAAT) Market Scope
U.K. Molecular Point of care Testing (Using NAAT) Market Segmentation & Scope
Indication
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
Product
- Instruments
- Consumables & Reagents
Distribution Channel
- Online Sales
- Third Party Distributor
- Direct Sales
Mode of Testing
- OTC Testing
- Prescription-Based Testing
End User
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
U.K. Molecular Point of care Testing (Using NAAT) Market Data Coverage Insights
| Study Period | 2024-2032 |
| Base Year | 2022 |
| Unit | Revenue in USD Billion |
| Market Value in 2024 | 3.60 USD Billion |
| Market Value in 2032 | 10.19 USD Billion |
| CAGR (2025-2032) | 18.24% |
| Historic Data | 2016-2023 |
| Market Segments Covered | Indication, Product, Distribution Channel, Mode of Testing, End User |
Regional Insights:
-
Leading Market (2024-2032): U.K., leading in terms of revenue 3.60 USD Billion in 2024
- Key Country: U.K., leading in terms of revenue with value of 3,599.04 USD Million in 2024.
Segments and Scope
-
U.K. Molecular Point of care Testing (Using NAAT) Market to 2032, By Indication
- Respiratory Infections Testing is the largest segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 2.30 USD Billion in the year 2024.
- Respiratory Infections Testing is the Fastest growing segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 19.54 % in forecast period 2025-2032.
-
U.K. Molecular Point of care Testing (Using NAAT) Market to 2032, By Product
- Consumables & Reagents is the largest segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 2.80 USD Billion in the year 2024.
- Consumables & Reagents is the Fastest growing segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 18.49 % in forecast period 2025-2032.
-
U.K. Molecular Point of care Testing (Using NAAT) Market to 2032, By Distribution Channel
- Direct Sales is the largest segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 2.23 USD Billion in the year 2024.
- Direct Sales is the Fastest growing segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 19.95 % in forecast period 2025-2032.
-
U.K. Molecular Point of care Testing (Using NAAT) Market to 2032, By Mode of Testing
- Prescription-Based Testing is the largest segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 3.40 USD Billion in the year 2024.
- Prescription-Based Testing is the Fastest growing segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 18.56 % in forecast period 2025-2032.
-
U.K. Molecular Point of care Testing (Using NAAT) Market to 2032, By End User
- Laboratories is the largest segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a revenue of 2.65 USD Billion in the year 2024.
- Laboratories is the Fastest growing segment in U.K. Molecular Point of care Testing (Using NAAT) Market to 2032 with a Growth rate of 19.32 % in forecast period 2025-2032.
U.K. Molecular Point of care Testing (Using NAAT) Market Company Share Analysis
| Company Name |
|
||
| Thermo Fisher Scientific Inc. | |||
| Abbott | |||
| Hologic, Inc. | |||
| Danaher | |||
| F. Hoffmann-La Roche Ltd. | |||
U.K. Molecular Point of care Testing (Using NAAT) Market Geographical Sales Distribution, 2018-2032 USD Billion
U.K. Molecular Point of care Testing (Using NAAT) Market Company Profiling
Industry Related Reports
Frequently Asked Questions
The U.K. Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Indication, Product, Distribution Channel, Mode of Testing, End User.
U.K. Molecular Point of care Testing (Using NAAT) Market was valued at USD 3.60(Revenue in USD Billion) in 2022.
U.K. Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 18.24% during the forecast period of 2024 to 2032.
The Prescription-Based Testing segment is expected to dominate the U.K. Molecular Point of care Testing (Using NAAT) Market, holding a largest market share of 3.40 USD Billion in 2024
Coming Soon....
U.K. Molecular Point of care Testing (Using NAAT) Market Scope
U.K. Molecular Point of care Testing (Using NAAT) Market Segmentation & Scope
Indication
- Others
- Gastrointestinal Tract Infections Testing
- Sexually Transmitted Infection (STI) Testing
- Respiratory Infections Testing
Product
- Instruments
- Consumables & Reagents
Distribution Channel
- Online Sales
- Third Party Distributor
- Direct Sales
Mode of Testing
- OTC Testing
- Prescription-Based Testing
End User
- Assisted Living Facilities
- Homecare
- Others
- Ambulatory Center
- Clinics
- Hospital
- Laboratories
Frequently Asked Questions
The U.K. Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Indication, Product, Distribution Channel, Mode of Testing, End User.
U.K. Molecular Point of care Testing (Using NAAT) Market was valued at USD 3.60(Revenue in USD Billion) in 2022.
U.K. Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 18.24% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Molecular Point of care Testing (Using NAAT) Market for final year is USD 10.19 (USD Billion).
U.K. Molecular Point of care Testing (Using NAAT) Market Company Profiling
Frequently Asked Questions
The U.K. Molecular Point of care Testing (Using NAAT) Market is segmented based on Segmentation Indication, Product, Distribution Channel, Mode of Testing, End User.
U.K. Molecular Point of care Testing (Using NAAT) Market was valued at USD 3.60(Revenue in USD Billion) in 2022.
U.K. Molecular Point of care Testing (Using NAAT) Market is projected to grow at a CAGR of 18.24% during the forecast period of 2024 to 2032.
The estimated market value of the U.K. Molecular Point of care Testing (Using NAAT) Market for final year is USD 10.19 (USD Billion).
HAVE A QUESTION?
Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.